In lines of these evidences, Callis et al.[43] reported cardiac hypertrophy and arrhythmia in mice with transgenic overexpression of miR-208a, which consequently repressed the expression of two negative regulatory target proteins: Thyroid hormone receptor-associated protein 1 (THRAP1) and myostatin. The gene discussed is MED13; the disease is Arrhythmia.